In a tabular form, classify below, with examples, indication, and clinical application
Asking for Preferences
It looks like the content you wanted classified didn't come through — your message only contains the instructions but the actual list is missing.
Could you please share what you'd like classified? For example:
- A list of drugs (e.g., antihypertensives, antibiotics)?
- Medical conditions or diseases?
- Laboratory tests or procedures?
- Something else entirely?
Please paste or type the items and I'll build the table for you right away.
In a tabular form, classify, sympathomimetic drugs, sympatholytics, cholinomimetic drugs, parasympatholytics, with examples, indications and clinical application for each
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I now have solid textbook-sourced content from Katzung, Goodman & Gilman, Barash, and Lippincott for all four drug classes. I'll now compile a comprehensive table.
Classification of Autonomic Drugs
Here is a comprehensive classification of the four major autonomic drug groups — sourced from Katzung's Basic & Clinical Pharmacology (16th ed.), Goodman & Gilman's Pharmacological Basis of Therapeutics, Lippincott Illustrated Reviews: Pharmacology, and Barash's Clinical Anesthesia.
1. Sympathomimetics (Adrenoceptor Agonists)
Drugs that mimic sympathetic nervous system activation by stimulating α- and/or β-adrenoceptors, directly or indirectly.
| Subclass | Mechanism | Examples | Indications | Clinical Applications |
|---|---|---|---|---|
| Non-selective α + β agonists | Stimulates α1, α2, β1, β2 receptors | Epinephrine (adrenaline), Norepinephrine | Anaphylaxis, cardiac arrest, severe bronchospasm | Epinephrine is first-line in anaphylaxis (IM); used in ACLS for cardiac arrest; added to local anesthetics to prolong duration |
| α1-selective agonists | Vasoconstriction via α1 | Phenylephrine, Oxymetazoline, Methoxamine | Nasal congestion, hypotension (intraoperative), mydriasis | Phenylephrine used for intraoperative hypotension and as a nasal decongestant; oxymetazoline as topical nasal spray |
| α2-selective agonists | Centrally reduces sympathetic outflow | Clonidine, Dexmedetomidine, Methyldopa | Hypertension, sedation (ICU), ADHD, opioid withdrawal | Dexmedetomidine for ICU sedation; clonidine for hypertension and ADHD; methyldopa in pregnancy-induced hypertension |
| β1-selective agonists | Increases heart rate and contractility | Dobutamine, Dopamine (high dose) | Cardiogenic shock, acute heart failure | Dobutamine for inotropic support in acute heart failure; dopamine at low doses also has renal/splanchnic vasodilation |
| β2-selective agonists | Bronchodilation, uterine relaxation | Albuterol (salbutamol), Salmeterol, Terbutaline, Formoterol | Asthma, COPD, preterm labor | Albuterol (SABA) for acute asthma attacks; salmeterol/formoterol (LABA) for maintenance; terbutaline for tocolysis in preterm labor |
| Indirect-acting sympathomimetics | Release stored catecholamines or inhibit reuptake | Amphetamine, Pseudoephedrine, Cocaine | ADHD, narcolepsy, nasal congestion | Amphetamine for ADHD and narcolepsy; pseudoephedrine as oral decongestant; cocaine as topical anesthetic + vasoconstrictor in ENT |
| Dopamine agonists | Stimulates dopamine D1/D2 receptors | Dopamine, Levodopa | Parkinson's disease, shock | Dopamine for septic/cardiogenic shock (dose-dependent effects); levodopa as mainstay of Parkinson's treatment |
2. Sympatholytics (Adrenoceptor Antagonists)
Drugs that block sympathetic effects by antagonizing adrenoceptors or reducing central sympathetic outflow. — Goodman & Gilman's, Block 9
| Subclass | Mechanism | Examples | Indications | Clinical Applications |
|---|---|---|---|---|
| Non-selective β-blockers | Block β1 + β2 receptors | Propranolol, Nadolol, Timolol | Hypertension, angina, arrhythmias, essential tremor, migraine prophylaxis | Propranolol for thyroid storm, performance anxiety, migraine prevention; timolol eye drops for glaucoma |
| β1-selective (cardioselective) blockers | Preferentially block β1 | Metoprolol, Atenolol, Bisoprolol, Esmolol | Hypertension, heart failure, post-MI, AF rate control | Metoprolol/bisoprolol reduce mortality in heart failure (HFrEF); esmolol (IV, ultra-short) for intraoperative tachycardia and AF |
| β-blockers with ISA | Partial β agonist + antagonist | Pindolol, Acebutolol | Hypertension (less resting bradycardia) | Used in patients with bradycardia at rest who still need β-blockade |
| α1-selective blockers | Block α1 → vasodilation | Prazosin, Doxazosin, Terazosin, Tamsulosin | Hypertension, benign prostatic hyperplasia (BPH) | Tamsulosin/doxazosin for BPH (urinary retention); prazosin for PTSD nightmares and hypertension |
| Non-selective α-blockers | Block α1 + α2 | Phentolamine, Phenoxybenzamine | Pheochromocytoma, hypertensive crisis | Phenoxybenzamine for pre-operative preparation in pheochromocytoma; phentolamine for hypertensive emergencies |
| Combined α + β blockers | Block α1 + β1 + β2 | Labetalol, Carvedilol | Hypertension (including in pregnancy), heart failure | Labetalol IV for hypertensive emergencies and pre-eclampsia; carvedilol reduces mortality in HFrEF |
| Centrally acting sympatholytics | α2 agonists reducing central sympathetic outflow | Clonidine, Methyldopa, Dexmedetomidine, Moxonidine | Hypertension, ICU sedation, opioid withdrawal | Clonidine for hypertension, opioid/alcohol withdrawal; methyldopa preferred in gestational hypertension; dexmedetomidine for ICU sedation |
3. Cholinomimetics (Parasympathomimetics)
Drugs that mimic acetylcholine by directly activating cholinergic receptors (muscarinic/nicotinic) or by inhibiting acetylcholinesterase to increase ACh levels. — Lippincott Pharmacology; Barash Clinical Anesthesia
| Subclass | Mechanism | Examples | Indications | Clinical Applications |
|---|---|---|---|---|
| Direct-acting muscarinic agonists (choline esters) | Bind and activate muscarinic receptors (M1–M5) | Acetylcholine, Bethanechol, Carbachol, Methacholine | Urinary retention, glaucoma, postoperative ileus | Bethanechol for neurogenic bladder/urinary retention and postoperative ileus (does not cross BBB); carbachol as eye drops for glaucoma and intraoperative miosis |
| Direct-acting muscarinic alkaloids | Directly activate muscarinic receptors | Pilocarpine, Muscarine, Arecoline | Glaucoma, Sjögren's syndrome (dry mouth/eyes), pupil constriction | Pilocarpine eye drops for open-angle glaucoma; pilocarpine oral for xerostomia in Sjögren's syndrome |
| Nicotinic agonists | Activate nicotinic receptors (NMJ and autonomic ganglia) | Nicotine, Succinylcholine, Varenicline | Smoking cessation, NMJ blockade (neuromuscular facilitation) | Nicotine replacement therapy (patches, gum) for smoking cessation; varenicline (partial nicotinic agonist) for smoking cessation |
| Indirect-acting (reversible AChE inhibitors) | Inhibit acetylcholinesterase → ↑ ACh at all cholinergic synapses | Neostigmine, Pyridostigmine, Edrophonium, Physostigmine, Donepezil, Rivastigmine, Galantamine | Myasthenia gravis, reversal of NMJ blockade, Alzheimer's disease, glaucoma | Neostigmine/sugammadex to reverse neuromuscular blockade post-surgery; pyridostigmine for myasthenia gravis (acts peripherally, doesn't cross BBB); donepezil/rivastigmine for Alzheimer's dementia |
| Indirect-acting (irreversible AChE inhibitors) | Irreversibly phosphorylate acetylcholinesterase | Organophosphates (sarin, VX, malathion), Echothiophate | Glaucoma (echothiophate); nerve agent poisoning (toxicological) | Echothiophate eye drops historically for glaucoma; organophosphate poisoning (pesticides) treated with atropine + pralidoxime (2-PAM) |
4. Parasympatholytics (Muscarinic Antagonists / Anticholinergics)
Drugs that block muscarinic acetylcholine receptors, opposing parasympathetic effects. Also called antimuscarinic agents — the preferred term. — Katzung 16th ed.; Fuster & Hurst's The Heart
| Subclass | Mechanism | Examples | Indications | Clinical Applications |
|---|---|---|---|---|
| Tertiary amine antimuscarinics (CNS-penetrating) | Block muscarinic receptors centrally and peripherally | Atropine, Scopolamine, Hyoscine, Benztropine, Trihexyphenidyl | Bradycardia, organophosphate poisoning, motion sickness, Parkinson's disease | Atropine for symptomatic bradycardia and asystole (ACLS), and as antidote in organophosphate poisoning; scopolamine transdermal for motion sickness; benztropine/trihexyphenidyl for Parkinson's (drug-induced extrapyramidal symptoms) |
| Quaternary amine antimuscarinics (CNS-sparing) | Peripheral muscarinic blockade only; does not cross BBB | Ipratropium, Tiotropium, Glycopyrrolate, Homatropine, Hyoscine butylbromide | COPD, asthma, peptic ulcer, GI spasm, perioperative antisecretion | Ipratropium (inhaled) for COPD exacerbations and asthma; tiotropium (LAMA) for COPD maintenance; glycopyrrolate perioperatively to reduce secretions; hyoscine butylbromide for IBS/bowel spasm |
| Bladder-selective antimuscarinics | Block M3 receptors in detrusor muscle | Oxybutynin, Tolterodine, Solifenacin, Darifenacin, Fesoterodine | Overactive bladder (OAB), urinary urge incontinence | Oxybutynin/tolterodine reduce urinary frequency and urgency; solifenacin/darifenacin more M3-selective (fewer CNS side effects) |
| Ophthalmic antimuscarinics | Block M3 → mydriasis + cycloplegia | Tropicamide, Cyclopentolate, Atropine (topical) | Fundoscopic examination, uveitis, refraction testing | Tropicamide (short-acting) for pupil dilation in eye exams; cyclopentolate for cycloplegic refraction; atropine drops for amblyopia treatment |
| Anti-ulcer antimuscarinics | Reduce gastric acid via M1 blockade | Pirenzepine, Propantheline | Peptic ulcer disease | Pirenzepine (M1-selective) reduces gastric acid secretion; largely replaced by PPIs but still used in some settings |
Quick Summary Comparison
| Drug Class | Nervous System Action | Key Receptor Target | Signature Effect | Mnemonic/Hallmark |
|---|---|---|---|---|
| Sympathomimetics | Activates SNS | α, β adrenoceptors | ↑HR, ↑BP, bronchodilation, mydriasis | "Fight or flight" ON |
| Sympatholytics | Blocks/inhibits SNS | α, β adrenoceptors | ↓HR, ↓BP, bronchoconstriction possible | "Fight or flight" OFF |
| Cholinomimetics | Activates PNS | Muscarinic + Nicotinic | ↓HR, ↑secretions, miosis, bronchospasm, ↑GI motility | "DUMBELS/SLUDGE" (toxidrome) |
| Parasympatholytics | Blocks PNS | Muscarinic (M1–M5) | ↑HR, dry mouth, mydriasis, urinary retention, ↓GI motility | "Dry as a bone, blind as a bat, red as a beet, hot as Hades, mad as a hatter" |
Sources: Katzung's Basic & Clinical Pharmacology, 16th ed. • Goodman & Gilman's Pharmacological Basis of Therapeutics • Lippincott Illustrated Reviews: Pharmacology • Barash, Cullen & Stoelting's Clinical Anesthesia, 9th ed. • Fuster & Hurst's The Heart, 15th ed.
This is a shared conversation. Sign in to Orris to start your own chat.